These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1924277)

  • 41. Morphometric grading in breast cancer: thresholds for mitotic counts.
    Kronqvist P; Kuopio T; Collan Y
    Hum Pathol; 1998 Dec; 29(12):1462-8. PubMed ID: 9865834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphometry of breast cancer. I. Comparison of the primary tumours and the axillary lymph node metastases.
    Van der Linden HC; Baak JP; Smeulders AW; Lindeman J; Meyer CJ
    Pathol Res Pract; 1986 May; 181(2):236-42. PubMed ID: 3737478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The value of morphometry to classic prognosticators in breast cancer.
    Baak JP; Van Dop H; Kurver PH; Hermans J
    Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoma of the breast in children.
    Eskelinen M; Vainio J; Tuominen L; Vihko R; Klemi P; Collan Y
    Z Kinderchir; 1990 Feb; 45(1):52-5. PubMed ID: 2321426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.
    Buhmeida A; Al-Maghrabi J; Merdad A; Al-Thubaity F; Chaudhary A; Gari M; Abuzenadah A; Collan Y; Syrjänen K; Al-Qahtani M
    Anticancer Res; 2011 Jan; 31(1):97-103. PubMed ID: 21273586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189.
    Simpson JF; Gray R; Dressler LG; Cobau CD; Falkson CI; Gilchrist KW; Pandya KJ; Page DL; Robert NJ
    J Clin Oncol; 2000 May; 18(10):2059-69. PubMed ID: 10811671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer.
    van Diest PJ; Matze-Cok E; Baak JP
    J Clin Pathol; 1991 May; 44(5):416-8. PubMed ID: 2045501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitotic indexes as prognostic predictors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mitotic conditions in primary and metastatic nodes of breast and cervix cancer].
    Ermolenko LM
    Arkh Patol; 1979; 41(8):50-3. PubMed ID: 485886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.
    Ladekarl M; Jensen V
    Virchows Arch; 1995; 427(3):265-70. PubMed ID: 7496595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.
    Aziz S; Wik E; Knutsvik G; Klingen TA; Chen Y; Davidsen B; Aas H; Aas T; Akslen LA
    PLoS One; 2016; 11(3):e0150979. PubMed ID: 26954367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of prognostic features in the cytology of effusions due to mammary cancer.
    Towers KJ; Melamed MR
    Acta Cytol; 1979; 23(1):30-4. PubMed ID: 285549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Total number of cancer cell nuclei and mitoses in breast tumors estimated by the optical disector.
    Ladekarl M; Jensen V; Nielsen B
    Anal Quant Cytol Histol; 1997 Aug; 19(4):329-37. PubMed ID: 9267566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the prognostic value of four methods to assess mitotic activity in 186 invasive breast cancer patients: classical and random mitotic activity assessments with correction for volume percentage of epithelium.
    Jannink I; van Diest PJ; Baak JP
    Hum Pathol; 1995 Oct; 26(10):1086-92. PubMed ID: 7557941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands.
    Baak JP; van Diest PJ; Ariens AT; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH; Kwee WS; Los J; Peterse HC
    Pathol Res Pract; 1989 Nov; 185(5):664-70. PubMed ID: 2696948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer.
    van der Linden JC; Baak JP; Lindeman J; Hermans J; Meyer CJ
    J Clin Pathol; 1987 Mar; 40(3):302-6. PubMed ID: 3558864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitotic frequency as a prognostic factor in breast cancer.
    Biesterfeld S; Noll I; Noll E; Wohltmann D; Böcking A
    Hum Pathol; 1995 Jan; 26(1):47-52. PubMed ID: 7821916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mitotic conditions in different variants of lymphogranulomatosis].
    Kir'ianov NA; Kazantseva IA
    Arkh Patol; 1979; 41(9):28-32. PubMed ID: 496692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.
    Pantanowitz L; Hartman D; Qi Y; Cho EY; Suh B; Paeng K; Dhir R; Michelow P; Hazelhurst S; Song SY; Cho SY
    Diagn Pathol; 2020 Jul; 15(1):80. PubMed ID: 32622359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.